Shikonin inhibits the growth and N-acetylation of 2-aminofluorene in Helicobacter pylori from ulcer patients

Anticancer Research

Volumn 24, Issue 3 A, 2004, Pages 1587-1592

  Kuo, Hsiu Maan ^a   Hsia, Te Chun ^c   Chuang, Yao Chen ^b   Lu, Hsu Feng ^d   Lin, Shuw Yun ^e   Chung, Jing Gung ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHUNGTAI INST HLTH SCI TECHNOL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^e HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

2 Aminofluorene; Gastric cancer; Helicobacter pylori; N acetyl 2 aminofluorene; N acetyltransferase; Shikonin

Indexed keywords

2 FLUORENYLAMINE; ARYLAMINE ACETYLTRANSFERASE; SHIKONIN;

ACETYLATION; APOPTOSIS; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIOSTASIS; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DRUG ACTIVITY; ENZYME ACTIVITY; GROWTH INHIBITION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ACETYLATION; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARYLAMINE N-ACETYLTRANSFERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORENES; HELICOBACTER PYLORI; HUMANS; KINETICS; NAPHTHOQUINONES; PEPTIC ULCER;

EID: 3242684415     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Weber WW and Hein DW: N-acetylation pharmacogenetics. Pharmacol Rev 37: 25-79, 1985.
2. Weber WW: The Acetylator Genes and Drug Response, Oxford University Press, New York, 1987.
3. Tannen RH and Weber WW: Inheritance of acetylator phenotype in mice. J Pharm Exp Thera 213: 480-484, 1980.
4. Hein DW, Omichinski JG, Brewer JA and Weber WW: A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. J Pharm Exp Thera 220: 8-15, 1982.
5. Ilett KK, David BM, Detchon P, Castledon WM and Kwa R: Acetylator phenotype in colorectal carcinoma. Cancer Res 47: 1466-1469, 1987.
6. Lang NP, Chu DZJ, Hunter CF, Kendell DC, Flammang JJ and Kadlubar F: Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg 121: 1259-1261, 1987.
7. Cartwright RA, Glasham RW, Rogers HJ, Ahmad RA, Barham-Hall R, Higgins DE and Kaha MA: The role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer. Lancet 2: 842-846, 1982.
8. Blum M, Grant DM, McBride W, Heim M and Myere UA: Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 9: 193-203, 1990.
9. Ohsako S and Deguchi T: Cloning and expression of cDNAs for polymorphic and monomorphic N-acetyltransferase from human liver. J Biol Chem 265: 4630-4634, 1990.
10. Warren JR and Marshall BJ: Unidentifield curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1: 1273-1275, 1983.
11. Rauws EAJ, Langenberg W and Houthaff HJ: Camplobacter pylori associated chronic active antral gastritis: A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterol 94: 33-40, 1983.
12. Kato J, Tominaga S and Ito Y: A prospective study of atrophic gastritis and stomach cancer risk. Jpn J Cancer Res 83: 1137-1142, 1992.
13. Marshall B: Campylobacterpylori and gastritis. J Infect Dis 153: 650-657, 1986.
14. Dixon MF: Campylobacter pylori and Chronic Gastritis. Campylobacter pylori and Gastroduodenal Disease. Oxford Blackwell Scientific Publications, 106-116, 1989.
15. Marshall B, Goodfwin CS and Warren JR: Prospective double-blind trial of duodenal ucler relapse after eradication of Campylobacterpylori. Cancer 2: 1437-1447, 1988.
16. Hentschel E, Brandstatter G, Dragosics B, Hirschi AM, Nemec H, Schutze K, Taufer M and Wurzer H: Effect of ranitidine and ampicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 328: 308-312, 1993.
17. Seppala K, Pikkarainen P, Sipponen P, Kivilaakso E, Gormsen MH and Finnish T: Gastric Ulcer Study Group. Cure of peptic gastric ulcer associated with erradication of Helicobacter pylori. Gut 36: 834-837, 1995.
18. Hsia T, Kimura Y, Takada K, Suzuki F and Takigawa M: Shikonin, an ingredient of Lithospermum erythrorhizon, inhibits angiogenesis in vivo and in vitro. Anticancer Res 18: 783-790, 1998.
19. Yoon Y, Kim YO, Lim NY, Jeon WK and Sung HJ: Shikonin, an ingredient of Lithospermum erythrorhizon induced apoptosis in HL-60 human premyelocytic leukemia cell line. Planta Medica 65: 532-535, 1999.
20. Fujii N, Yamashita Y, Arima Y, Nagashima M and Nakano H: Induction of topoisomerase II-mediated DNA cleavage by the plant naphthoquinones plumbagin and shikonin. Antimicrob Agents Chemother 36: 2589-2594, 1992.
21. Kamei R, Kitagawa Y, Kadokura M, Hattori F, Hazeki O, Ebina Y, Nishihara T and Oikawa S: Shikonin stimulates glucose uptake in 3T3-L1 adipocytes via an insulin-independent tyrosine kinase pathway. Biochem Biophys Res Commun 292: 642-651, 2002.
22. Lu Q, Liu W, Ding J, Cai J and Duan W: Shikonin derivatives: synthesis and inhibition of human telomerase. Bioorg Med Chem Lett 20: 1375-1378, 2002.
23. Chung JG, Wang HH, Tsou MF, Hsien SE, Lo HH, Yen YS, Chang SS, Wu LT, Lee JH and Hung CF: Evidence for arylamine N-acetyltransferase in the bacteria Helicobacterpylori. Toxico Lett 91: 63-71, 1997.
24. Wang HH and Chung JG: Emodin-induced inhibition of growth and DNA damage in the Helicobacter pylori. Current Microbiol 35: 262-266, 1997.
25. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt Biochem 72: 248-254, 1976.
26. Cleland WW: The statistical analysis of enzyme kinetics data. Adv Enzymol 29: 1-32, 1967.
27. Minchin RF, Reeves PT, Teitel CH, McManus ME, Mojarrabi T, Ilett KF and Kadlubar FF: N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferase expressed in COS-1 cells. Biochem Biophys Res Commun 185: 839-844, 1992.
28. Grant DM, Josephy PD and Lord HI: Salmonella typhimurium strains expressing human arylamine N-acetyltransferase: metabolism and mutagenic activation of aromatic amines. Cancer Res 52: 3961-3964, 1992.
29. Grant DM, Blum M, Beer M and Meyer UA: Monomorphic and polymorphic human arylamine N-acetyltransferase: a comparison of liver isozymes and expressed products of two coloned genes. Mol Pharmacol 39: 184-191, 1991.
30. Larsen GL: Deconjugation of biliary metabolites by microfloral β-glucronidase, sulphatase and cysteine conjugate β-lyase and their subsequent enterohepatic circulation. In: Rowland I (ed.), Role of Gut Flora in Toxicity and Cancer, pp 79-107 London: Academic Press, 1988.
31. Kinouchi T, Kataoka K, Miyanishi K, Akimoto S and Ohnishi Y: Biological activities of the intestinal microflora in mice treated with antibiotics or untreated and the effects of the microflora on absorption and metabolic activation of orally administrated glutathione conjugates of K-region epoxides of 1-nitropyrene. Carcinogenesis (Lond.) 14: 869-874, 1993.
32. Okumuro F, Uedo O, Kitamuru S and Tatsumi K: N-acetylation and N-formation of carcinogenic arylamines and related compounds in dogs. Carcinogenesis 1: 71-76, 1995.
33. Lo HH and Chung JG: The effects of plant phenolics, caffeic acid, chlorogenic acid and ferulic acid on arylamine N-acetyltransferase activities in human gastrointestinal microflora. Anticancer Res 19: 133-140, 1999.
34. Zubay GL, Parson WW and Vance DE: Principles of Biochemistry. pp.135-153. Wm. C. Brown Publishers. 1955,
35. Einisto P, Watanabe M, Ishidate M and Nohmi T: Mutagenicity of 30 chemicals in S. typhimurium possessing different nitroreductase or O-acetyltransferase activities. Mutation Res 259: 95-102, 1991.